The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases

Lutfu Askin; Okan  Tanrıverdi; Husna Sengul  Askin

doi:10.1590/SciELOPreprints.628

##article.authors##

Lutfu Askin Adiyaman Universitesi Egitim ve Arastirma Hastanesi – Cardiology, Adıyaman, Centry – Turkey
Okan Tanrıverdi Adiyaman Universitesi Egitim ve Arastirma Hastanesi – Cardiology, Adıyaman, Centry – Turkey
Husna Sengul Askin Adiyaman Universitesi Egitim ve Arastirma Hastanesi – Infectious Disease, Adıyaman, Centry – Turkey

DOI:

https://doi.org/10.1590/SciELOPreprints.628

Keywords:

Coronavirus, COVID 19, Cardiovascular Diseases/complications, Comorbidity, Hypertension, Heart Failure, Myocarditis, Acute Respiratory Syndrome, Pandemic, Mortality, Hospitalization, Critical Care

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19.